PRKAA1 and metabolic dysfunction-associated steatotic liver disease: We found that salidroside-stimulated AMPK activation could reduce lipid accumulation in muscle and liver tissues of db/db mice, suggesting that salidroside may be used for the treatment of NAFLD [25].